Prophylactic/therapeutic agent for dry eye

Abstract

This invention provides a prophylactic and therapeutic agent for dry eye, having new ingredients to reduce the deterioration of the lacrimal secretory ability and to inhibit the generation of radical oxygen in lacrimal gland tissue. The prophylactic and therapeutic agent for dry eye of this invention contains the maqui berry extract as the active substance of this invention, i.e. containing delphinidin glycoside extracted from the maqui berry and at least one or more of the active substances delphinidin-3-sambubioside-5-glucoside, delphinidin-3,5-diglucoside, delphinidin-3-sambubioside and delphinidin-3-glucoside, preferably delphinidin-3,5-diglucoside.

Description

TECHNICAL FIELD[0001]This invention relates to compositions that allow the eye to increase lacrimal secretion, specifically to increase the amount of lacrim al secretion that has been lessened by functional deterioration due to an excessive use of the eyes.TECHNICAL BACKGROUND[0002]Lacrimal fluid is a thin layer of liquid approximately 7 μm thick that covers the outermost surface of the eyeball. Lacrimal fluid of the outermost surface consists of a three-layer structure of an oil layer, a water layer and a mucin layer. These layers influence one another in adjusting the structure of the lacrimal fluid. Each layer of the lacrimal fluid contains various ingredients such as protein including lactoferrin, lysozyme, IgA (immunoglobulin A), IgG (immunoglobulin G), albumin or the like, wax, cholesterol, glucide, mucin or the like. The function of the lacrimal fluid containing these ingredients is to keep the ocular surface moist to prevent infection from pathogens or the like that enter fr...

AI Technical Summary

Benefits of technology

The invention is about a new ingredient in a berry called maqui berry extract that can protect against dry eye. The extract contains a compound called delphinidin glycoside, which helps to reduce the symptoms of dry eye by improving lacrimal gland function and reducing the generation of harmful molecules. This ingredient can be used as a preventive or therapeutic treatment for dry eye.

Problems solved by technology

However, if there are abnormalities in the lacrimal secretion, resulting in changes in the amount or quality of secretion, thus resulting in an increase in the amount of evaporation of the lacrimal liquid or the like, the lacrimal liquid may not function well.

One of the more noticeable causes is the excessive viewing of visual display terminals (VDT).

As computers are being frequently used, an increasing number of people are complaining of eyestrain and of symptoms of dry eye and of impaired vision, possibly caused by VDT work, which is starting to become an issue as a serious health problem in advanced industrial countries.

It is suspected that excessive use of the eyes causes oxidant stress.

However, each of these remedies is just a temporary, supportive one and insufficient.

Images